These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8506453)

  • 21. Melatonin in patients with reduced REM sleep duration: two randomized controlled trials.
    Kunz D; Mahlberg R; Müller C; Tilmann A; Bes F
    J Clin Endocrinol Metab; 2004 Jan; 89(1):128-34. PubMed ID: 14715839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The treatment of narcolepsy-cataplexy with nocturnal gamma-hydroxybutyrate.
    Broughton R; Mamelak M
    Can J Neurol Sci; 1979 Feb; 6(1):1-6. PubMed ID: 264152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
    Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
    Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter, double-blind, placebo-controlled, randomized, Phase 1b crossover trial comparing two doses of ulotaront with placebo in the treatment of narcolepsy-cataplexy.
    Szabo ST; Hopkins SC; Lew R; Loebel A; Roth T; Koblan KS
    Sleep Med; 2023 Jul; 107():202-211. PubMed ID: 37209427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J; Swick T; Bogan R; Lai C; Carter LP
    Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selegiline in the treatment of narcolepsy.
    Hublin C; Partinen M; Heinonen EH; Puukka P; Salmi T
    Neurology; 1994 Nov; 44(11):2095-101. PubMed ID: 7969965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Advances in the psychopharmacological management of the narcoleptic patient].
    Salín-Pascual RJ; de la Fuente JR
    Acta Psiquiatr Psicol Am Lat; 1985 Mar; 31(1):62-8. PubMed ID: 4050495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sleep-wake patterns, non-rapid eye movement, and rapid eye movement sleep cycles in teenage narcolepsy.
    Xu X; Wu H; Zhuang J; Chen K; Huang B; Zhao Z; Zhao Z
    Sleep Med; 2017 May; 33():47-56. PubMed ID: 28449905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of acute administration of sodium oxybate on nocturnal sleep polysomnography and on multiple sleep latency test in narcolepsy with cataplexy.
    Plazzi G; Pizza F; Vandi S; Aricò D; Bruni O; Dauvilliers Y; Ferri R
    Sleep Med; 2014 Sep; 15(9):1046-54. PubMed ID: 25087195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The spectrum of REM sleep-related episodes in children with type 1 narcolepsy.
    Antelmi E; Pizza F; Vandi S; Neccia G; Ferri R; Bruni O; Filardi M; Cantalupo G; Liguori R; Plazzi G
    Brain; 2017 Jun; 140(6):1669-1679. PubMed ID: 28472332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy.
    Mamelak M; Black J; Montplaisir J; Ristanovic R
    Sleep; 2004 Nov; 27(7):1327-34. PubMed ID: 15586785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Narcolepsy-cataplexy. I. Clinical and electrophysiologic characteristics.
    Kales A; Cadieux RJ; Soldatos CR; Bixler EO; Schweitzer PK; Prey WT; Vela-Bueno A
    Arch Neurol; 1982 Mar; 39(3):164-8. PubMed ID: 7065934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Narcolepsy--master of disguise: evidence-based recommendations for management.
    Mohsenin V
    Postgrad Med; 2009 May; 121(3):99-104. PubMed ID: 19491546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of gamma-hydroxybutyrate on nocturnal and diurnal sleep of normal subjects: further considerations on REM sleep-triggering mechanisms.
    Lapierre O; Montplaisir J; Lamarre M; Bedard MA
    Sleep; 1990 Feb; 13(1):24-30. PubMed ID: 2406848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of narcolepsy and sleep apnea with gammahydroxybutyrate: a clinical and polysomnographic case study.
    Mamelak M; Webster P
    Sleep; 1981; 4(1):105-11. PubMed ID: 7232968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group.
    Ann Neurol; 1998 Jan; 43(1):88-97. PubMed ID: 9450772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.
    McClellan KJ; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):311-24. PubMed ID: 27521015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults.
    Mignot E; Lin L; Finn L; Lopes C; Pluff K; Sundstrom ML; Young T
    Brain; 2006 Jun; 129(Pt 6):1609-23. PubMed ID: 16597649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of narcolepsy with L-tyrosine: double-blind placebo-controlled trial.
    Elwes RD; Crewes H; Chesterman LP; Summers B; Jenner P; Binnie CD; Parkes JD
    Lancet; 1989 Nov; 2(8671):1067-9. PubMed ID: 2572797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study.
    Ruoff C; Swick TJ; Doekel R; Emsellem HA; Feldman NT; Rosenberg R; Bream G; Khayrallah MA; Lu Y; Black J
    Sleep; 2016 Jul; 39(7):1379-87. PubMed ID: 27166238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.